Stephanie Tapp

Dartmouth Institute for Health Policy and Clinical Practice

MedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Cost effectiveness of DPYD genotyping to screen for dihydropyrimidine dehydrogenase (DPD) deficiency prior to adjuvant chemotherapy for colon cancer.”.

Cost effectiveness of DPYD genotyping to screen for dihydropyrimidine dehydrogenase (DPD) deficiency prior to adjuvant chemotherapy for colon cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.55

N/A

0DataRank · unranked

5 citations

Stephanie Tapp, Allan T. Daly, Jonathan Busam, Anna N.A. Tosteson, Gabriel A. Brooks

Cost-effectiveness of DPYD Genotyping Prior to Fluoropyrimidine-based Adjuvant Chemotherapy for Colon Cancer

Clinical Colorectal Cancer(2022)10.1016/j.clcc.2022.05.001

N/A

0DataRank · unranked

40 citations

Stephanie Tapp, Allan T. Daly, Jonathan A. Busam, Anna N.A. Tosteson, Gabriel A. Brooks